Alan S. Florjancic
AbbVie (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Peptidase Inhibition and Analysis, Cancer-related Molecular Pathways, Protease and Inhibitor Mechanisms, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Phenoxyphenyl SulfoneN-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors(2001)103 cited
- → Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists(2007)49 cited
- → Structure–activity relationships of novel potent MurF inhibitors(2003)47 cited
- → A new strategy for the synthesis of axially chiral biaryl compounds(1994)39 cited
- → Structure‐based Optimization of MurF Inhibitors(2005)36 cited
- → Discovery and Evaluation of a Series of 3-Acylindole Imidazopyridine Platelet-Activating Factor Antagonists(1998)34 cited
- → Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists(2008)31 cited
- → Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195(2013)29 cited
- → Aminopyrimidinone Cdc7 Kinase Inhibitors(2012)22 cited
- → From Bacterial Genomes to Novel Antibacterial Agents: Discovery, Characterization, and Antibacterial Activity of Compounds that Bind to HI0065 (YjeE) from Haemophilus influenzae(2007)22 cited